(Allergan plc)

	AGN latest price $166.3609 (-0.11%) ($165.0703 - $168.6392) on Wed. Jan. 3, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.77% (three month average)
RSI	45
Latest Price	$166.3609(-0.11%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.7% a day on average for past five trading days.
Weekly Trend	AGN declines -1.1% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Growth stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(48%)    ARKG(46%)    SPY(46%)
Factors Impacting AGN price	AGN will decline at least -0.885% in a week (0% probabilities).   VIXM(-31%)    TLT(-20%)    UUP(-18%)    GDXJ(-5%)    SHY(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.885% (StdDev 1.77%)
Hourly BBV	0 ()
Intraday Trend	-1.1%

5 Day Moving Average	$163.14(1.97%)
10 Day Moving Average	$162.97(2.08%)
20 Day Moving Average	$164.18(1.33%)
To recent high	-18.6%
To recent low	4%
Market Cap	$54.849b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed